Mechano-Growth Factor

sequence comparison mgf
IGF-1: one gene, many proteins. A) A schematic representation of the IGF-1 gene and its locally produced splice variants. The black boxes denote the insert in exon 5 (49 bp in human, 52 bp in gerbil and other species studied), which gives rise to alternatively spliced MGF isoform. B) The gerbil C-terminal MGF peptide sequence shows a high degree of homology with E-domains from other species. Based on the consensus sequence, the C-terminal MGF peptide was synthesized. 

Dluzniewska J, et al. FASEB J. 2005 Sep 6; [Epub ahead of print]

The ischemic stroke is the third leading cause of death in developed countries. The C-terminal peptide of mechano-growth factor (MGF), an alternatively spliced variant of insulin-like growth factor 1 (IGF-1), was found to function independently from the rest of the molecule and showed a neuroprotective effect in vivo and in vitro. In vivo, in a gerbil model of transient brain ischemia, treatment with the synthetic MGF C-terminal peptide provided very significant protection to the vulnerable neurons. In the same model, ischemia evoked increased expression of endogenous MGF in the ischemia-resistant hippocampal neurons, suggesting that the endogenous MGF might have an important neuroprotective function. In an in vitro organotypic hippocampal culture model of neurodegeneration, the synthetic peptide was as potent as the full-length IGF-1 while its effect lasted significantly longer than that of recombinant IGF-1. While two peptides showed an additive effect, the neuroprotective action of the C-terminal MGF was independent from the IGF-1 receptor, indicating a new mode of action for this molecule. Although MGF is known for its regenerative capability in skeletal muscle, our findings demonstrate for the first time a neuroprotective role against ischemia for this specific IGF-1 isoform. Therefore, the C-terminal MGF peptide has a potential to be developed into a therapeutic modality for the prevention of neuronal damage.

Dluzniewska J, Sarnowska A, Beresewicz M, et al. A strong neuroprotective effect of the autonomous C-terminal peptide of IGF-1 Ec (MGF) in brain ischemia. FASEB J. 2005;19(13):1896-8.

The physiological function of a recently cloned splice variant of insulin-like growth factor-I (IGF-I; mechano growth factor (MGF)) was studied using an in vitro cell model. Unlike mature IGF-I, the distinct E domain of MGF inhibits terminal differentiation whilst increasing myoblast proliferation. Blocking the IGF-I receptor with a specific antibody indicated that the function of MGF E domain is mediated via a different receptor. The results provide a basis for localized tissue adaptation and helps explain why loss of muscle mass occurs in the elderly and in dystrophic muscle in which MGF production is markedly affected.

Yang SY, Goldspink G. Different roles of the IGF-I Ec peptide (MGF) and mature IGF-I in myoblast proliferation and differentiation. FEBS Lett. 2002;522(1-3):156-60.

Representative immunoblot analysis of the expression of endogenous MGF.
Representative immunoblot analysis of the expression of endogenous MGF. The hippocampi (C-control) and postischemic at 3, 24, 48, and 72 h after reperfusion were divided into vulnerable (CA1) and the resistant (CA2-3, DGabdominal, AbP) parts. Note the rapid increase and sustained expression of MGF only in the abdominal part (arrow). There were always two immunopositive bands present; the identity of the larger-size band is not clear. Antibody was obtained by immunization with synthetic C-terminal MGF peptide shown on blots as a positive control (smaller band in MGF lane) and does not cross-react with the recombinant IGF-1 peptide (IGF-1 lane). 

Related Products

Catalog# Product Standard Size Price
033-35 Mechano-Growth Factor (MGF) (Human) 100 µg $138
033-42 Mechano-Growth Factor (MGF) (Rat) 100 µg $138
H-033-35 Mechano-Growth Factor (MGF) (Human) - Antibody 100 µl $475
B-033-35 Mechano-Growth Factor (MGF) (Human) - Biotin Labeled 20 µg $285
B-G-033-35 Mechano-Growth Factor (MGF) (Human) - Biotin Labeled Purified IgG 100 µl $580
FC3-033-35 Mechano-Growth Factor (MGF) (Human) - Cy3 Labeled 1 nmol $391
FC3-G-033-35 Mechano-Growth Factor (MGF) (Human) - Cy3 Labeled Purified IgG 100 µl $686
FC5-033-35 Mechano-Growth Factor (MGF) (Human) - Cy5 Labeled 1 nmol $443
FC5-G-033-35 Mechano-Growth Factor (MGF) (Human) - Cy5 Labeled Purified IgG 100 µl $686
FG-033-35A Mechano-Growth Factor (MGF) (Human) - FAM Labeled 1 nmol $285
FG-G-033-35A Mechano-Growth Factor (MGF) (Human) - FAM Labeled Purified IgG 100 µl $580
FG-033-35B Mechano-Growth Factor (MGF) (Human) - FITC Labeled 1 nmol $285
FG-G-033-35B Mechano-Growth Factor (MGF) (Human) - FITC Labeled Purified IgG 100 µl $580
T-033-35 Mechano-Growth Factor (MGF) (Human) - I-125 Labeled 10 µCi $749
T-G-033-35 Mechano-Growth Factor (MGF) (Human) - I-125 Labeled Purified IgG 10 µCi $749
G-033-35 Mechano-Growth Factor (MGF) (Human) - Purified IgG Antibody 200 µg $475
FR-033-35 Mechano-Growth Factor (MGF) (Human) - Rhodamine Labeled 1 nmol $391
FR-G-033-35 Mechano-Growth Factor (MGF) (Human) - Rhodamine Labeled Purified IgG 100 µl $502
033-43 Mechano-Growth Factor (MGF) (Mouse) 100 µg $138